Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

418933

registered interest
date	15/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prescription Drugs: Internet
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to (a) reduce and (b) monitor the sale of prescription drugs on the internet.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	10263
answer	answer is ministerial correction date of answer 21/09/2015 answer text <p>In the United Kingdom, all categories of medicines may be traded online legally but in the case of prescription only medicines (POM) and pharmacy (P) medicines, these may only be sold or supplied to the public through registered pharmacy premises (by or under the supervision of a pharmacist). Additionally, POMs may only be supplied in response to a prescription from an authorised healthcare professional.</p><p> </p><p> </p><p> </p><p>A UK registered pharmacy may have a presence on the internet; however the requirements of legislation apply equally to both UK internet pharmacies and bricks-and-mortar premises.</p><p> </p><p> </p><p> </p><p>The Medicines and Healthcare products Regulatory Agency (MHRA) monitors the internet for websites operating outside legal requirements and, in collaboration with Internet Service Providers, takes steps to close down sites both in the UK and abroad. The MHRA has closed down 1,973 websites (including those based overseas) during 2015 alone and brought into compliance many others.</p><p> </p><p> </p><p> </p><p>The illegal sale and supply of medicines via Internet poses considerable risks to UK patients but this is in essence a global problem and the MHRA is working with other regulators, law enforcement authorities and Government Departments within the UK, European Union and elsewhere to address the complex issues involved.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 21/09/2015 14:47:22 answering member 4020 label Biography information for George Freeman
tabling member	4131 label Biography information for Jim Shannon

418935

registered interest
date	15/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Breast Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what recent discussions he has had with the Royal Colleges on the development and use of progesterone and tamoxifen to treat breast cancer.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	10266
answer	answer is ministerial correction date of answer 21/09/2015 answer text <p>There have been no such discussions.</p><p> </p><p> </p><p> </p><p>Research into the use of progesterone in combination with tamoxifen for the treatment of breast cancer is still at an early stage and has not yet been trialled in humans.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 21/09/2015 14:41:04 answering member 4020 label Biography information for George Freeman
tabling member	4131 label Biography information for Jim Shannon

418936

registered interest
date	15/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Dementia: Diabetes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions he has had with the Royal College of Physicians on a link between type 2 diabetes and dementia; and what steps he is taking to treat dementia caused in that way.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	10243
answer	answer is ministerial correction date of answer 21/09/2015 answer text <p>NHS England is implementing the NHS Diabetes Prevention Programme, and it is possible that prevention of Type 2 diabetes may in the longer term reduce dementia risk, although at this point this is speculative rather than being based on evidence.</p><p> </p><p> </p><p> </p><p>The treatment of dementia associated with Type 2 diabetes is as for any dementia, although it is important to also address the Type 2 diabetes and vascular risk. People with dementia who also have diabetes need support to manage their condition.</p><p> </p><p> </p><p> </p><p>Improving the treatment and care of people with dementia, reducing the incidence of dementia and improving dementia research, is a key priority for the Government. That is why in February 2015, the Prime Minister launched his Challenge on Dementia 2020 as a successor to the Prime Minister’s Challenge on Dementia 2012-2015.</p><p> </p><p><strong> </strong></p><p> </p><p>My Rt. hon. Friend the Secretary of State has had and continues to have discussions on these matters with a range of organisations including the Royal College of Physicians.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 21/09/2015 15:01:16 answering member 3918 label Biography information for Jane Ellison
tabling member	4131 label Biography information for Jim Shannon

418940

registered interest
date	15/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assistance his Department provides to people addicted to legal highs.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	10258
answer	answer is ministerial correction date of answer 21/09/2015 answer text <p>The dependence-forming potential of many new psychoactive substances (NPS) is still largely unknown, and the number of people attending specialist drug treatment services is relatively small. If users need help, it will more likely be because they have acute NPS-related problems (eg, agitation, palpitations, seizures) and they will probably first present at accident and emergency (A&amp;E) departments.</p><p> </p><p> </p><p> </p><p>Local authorities are responsible for assessing drug treatment needs in their local areas and providing services to meet that need. This includes determining the scale of NPS use and harm in their areas and ensuring there are services to tackle that harm.</p><p> </p><p> </p><p> </p><p>Public Health England (PHE) supports local authorities in their work of assessing need and planning services, by improving data, intelligence and information sharing systems, to ensure prevention and treatment are as effective as they can be in the changing NPS market.</p><p> </p><p> </p><p> </p><p>PHE has produced an NPS toolkit for substance misuse commissioners which gives a broad overview of the challenges from NPS and provides commissioners with resources and advice to inform their work.</p><p> </p><p> </p><p> </p><p>PHE has also supported Project NEPTUNE, which is producing detailed and practical clinical guidance and tools for A&amp;E, drug treatment and other services that deal with people who have NPS problems.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 21/09/2015 14:54:24 answering member 3918 label Biography information for Jane Ellison
tabling member	4131 label Biography information for Jim Shannon

418943

registered interest
date	15/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Morquio Syndrome: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to ensure that NHS England funds homecare costs for patients currently in receipt of the Vimizim drug from BioMarin.
tabling member constituency	Leeds North West
tabling member printed	Greg Mulholland
uin	10374
answer	answer is ministerial correction date of answer 21/09/2015 answer text <p>NHS England can confirm that it does and will continue to reimburse costs incurred by National Health Service trusts for providing homecare for patients currently in receipt of Vimizim.</p><p> </p><p> </p><p> </p><p>NHS England remains committed to supporting any additional costs associated with the delivery of Vimizim to individuals who are continuing treatment following on from the clinical trial.</p><p> </p><p> </p><p> </p><p>This message was communicated in a letter from the Director of Specialised Commissioning, Richard Jeavons, to the Chief Executive of the Society for Mucopolysaccharide Diseases (The MPS Society), Christine Lavery, on 17 August.</p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 21/09/2015 14:34:02 answering member 4020 label Biography information for George Freeman
tabling member	1540 label Biography information for Greg Mulholland

418946

registered interest
date	15/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cardiovascular System: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether his Department plans to provide renal denervation for the treatment of high blood pressure on the NHS.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	10267
answer	answer is ministerial correction date of answer 21/09/2015 answer text <p>NHS England’s Clinical Commissioning Policy Statement <em>Renal Denervation for Resistant Hypertension</em>, published in April 2013, states that NHS England does not routinely commission renal denervation as a treatment for resistant hypertension.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 21/09/2015 14:59:39 answering member 3918 label Biography information for Jane Ellison
tabling member	4131 label Biography information for Jim Shannon

418948

registered interest
date	15/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pharmaceutical Price Regulation Scheme
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what his policy is on ringfencing Pharmaceutical Price Regulation Scheme payments specifically to pay for medicinal drugs.
tabling member constituency	North Antrim
tabling member printed	Ian Paisley
uin	10303
answer	answer is ministerial correction date of answer 21/09/2015 answer text <p>Pharmaceutical Price Regulation Scheme (PPRS) payments are allocated to each of the four countries of the United Kingdom on an agreed basis each year. It is a matter for the devolved health administrations to decide how to use the apportioned payments they receive from the PPRS.</p><p> </p><p> </p><p> </p><p>The Department ensures that all the income it receives from PPRS payments in England is reinvested in the National Health Service for patients’ benefit. The Department includes the expected PPRS payments in setting the NHS England allocations in advance of each year.</p><p> </p><p> </p><p> </p><p>NHS England is responsible for allocating its overall budget (which includes expected income from PPRS payments in England) between clinical commissioning groups, specialised commissioning etc. Following normal Government accounting rules, there is no separately identified or ring-fenced funding stream associated with the PPRS payments.</p><p> </p><p> </p><p> </p><p>The Government believes that NHS commissioners and providers are best placed to decide how to allocate their budgets to deliver improvements in the outcomes for patients. The PPRS includes a number of commitments for improving patient outcomes by improving access to clinically and cost effective medicines.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 21/09/2015 14:45:41 answering member 4020 label Biography information for George Freeman
tabling member	4129 label Biography information for Ian Paisley

418954

registered interest
date	15/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Naloxone
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment (a) Public Health England and (b) NICE have made of the current provision, availability and use of Naloxone in community settings for the treatment of drug overdose; and what commissioning guidance each such body has issued for this drug.
tabling member constituency	Dewsbury
tabling member printed	Paula Sherriff
uin	10380
answer	answer is ministerial correction date of answer 21/09/2015 answer text <p>The Government has accepted the advice from the Advisory Council on the Misuse of Drugs that naloxone needs to be more widely available. The Human Medicines (Amendment) (No.3) Regulations 2015 which come into effect on 1 October underpin the implementation of that decision.</p><p> </p><p> </p><p> </p><p>Public Health England (PHE) provides support to local authorities to carry out a Joint Strategic Needs Assessment (JSNA) in their local area each year. JSNAs identify the current and future health and care needs of the local population, including drug treatment services, and help build a robust evidence base of local needs.</p><p> </p><p> </p><p> </p><p>The drugs harm interventions section of the PHE Alcohol, Drugs and Tobacco Joint Strategic Needs Assessment support pack (<a href="http://www.nta.nhs.uk/healthcare-JSNA.aspx" target="_blank">http://www.nta.nhs.uk/healthcare-JSNA.aspx</a>) includes a checklist of questions for commissioners to consider. The checklist is titled ‘What questions should you ask to check you are following the evidence and best practice that supports the principle?’ and includes the question “Are effective overdose-awareness training and information, and naloxone provided for service users and their family/carers?”.</p><p> </p><p> </p><p> </p><p>In February 2015, PHE published advice for commissioners and providers on the provision of naloxone, so that commissioners and providers could take action to widen the availability of naloxone:</p><p> </p><p> </p><p> </p><p><a href="http://www.nta.nhs.uk/uploads/phetake-homenaloxoneforopioidoverdosefeb2015rev.pdf" target="_blank">http://www.nta.nhs.uk/uploads/phetake-homenaloxoneforopioidoverdosefeb2015rev.pdf</a></p><p> </p><p><strong> </strong></p><p> </p><p>The role of the National Institute for Health and Care Excellence (NICE) is to provide evidence based guidance, advice, quality standards and information services for the health, public health and social care sectors. It does not have responsibility for assessing the current provision, availability or use of medicines or treatments. We understand there are no plans to ask NICE to develop commissioning guidance on naloxone to treat opioid overdoses.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 21/09/2015 14:25:14 answering member 3918 label Biography information for Jane Ellison
tabling member	4426 label Biography information for Paula Sherriff

418698

registered interest
date	14/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Research: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 11 September 2015 to Question 8266, what representations he has received from (a) universities and (b) other research institutions on the future funding of research budgets; and if he will make a statement.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	10152
answer	answer is ministerial correction date of answer 21/09/2015 answer text <p>Correspondence records indicate that Ministers of the Department have received no letters from universities or research institutions specifically about future allocations to the Department’s budget for research and development following the 2015 Spending Review.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 21/09/2015 14:50:02 answering member 4020 label Biography information for George Freeman
tabling member	308 label Biography information for Mr Jim Cunningham

418699

registered interest
date	14/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Pay
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effect of the public sector pay freeze on NHS staff morale; and whether he plans to survey NHS staff on that matter.
tabling member constituency	Sheffield, Heeley
tabling member printed	Louise Haigh
uin	10139
answer	answer is ministerial correction date of answer 17/09/2015 answer text <p>National Health Service staff earning above £21,000 had their pay frozen during 2011/12 and 2012/13 with, since then, most staff receiving at least 1% increases. This approach to pay has helped protect jobs in the NHS and maintain services for patients.</p><p> </p><p> </p><p> </p><p>There is no evidence that the pay freeze affected staff morale. While the NHS Staff Survey, which provides the most comprehensive assessment of staff views about working in the NHS, does not directly measure staff morale, staff engagement, which includes staff motivation at work, staff recommending their trust as a place to work or receive treatment, and the percentage of staff able to contribute towards improvements at work, has remained high with a score of 3.76/5 in 2014 (latest available) rising from 3.68/5 in 2012 (the first year staff engagement was included).</p><p> </p><p> </p><p> </p> answering member constituency North East Bedfordshire answering member printed Alistair Burt question first answered 17/09/2015 15:58:15 answering member 1201 label Biography information for Alistair Burt
tabling member	4473 label Biography information for Louise Haigh